Medy-Tox Inc. (KOSDAQ:086900)
South Korea flag South Korea · Delayed Price · Currency is KRW
166,100
+2,100 (1.28%)
May 14, 2025, 11:40 AM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Biopharmaceutical Products
217.16B
Log In
Log In
Log In
Log In
Biopharmaceutical Products Growth
13.42%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Other
226.72M
Log In
Log In
Log In
Log In
South Korea
79.82B
Log In
Log In
Log In
Log In
South Korea Growth
19.66%
Log In
Log In
Log In
Log In
Asia
73.71B
Log In
Log In
Log In
Log In
Asia Growth
6.56%
Log In
Log In
Log In
Log In
America
48.30B
Log In
Log In
Log In
Log In
America Growth
10.69%
Log In
Log In
Log In
Log In
Middle East
8.54B
Log In
Log In
Log In
Log In
Middle East Growth
73.19%
Log In
Log In
Log In
Log In
Europe
6.56B
Log In
Log In
Log In
Log In
Europe Growth
0.15%
Log In
Log In
Log In
Log In
Other
226.72M
Log In
Log In
Log In
Log In
Africa
-
Log In
Log In
Log In
Log In
Africa Growth
-
Log In
Log In
Log In
Log In
Oceania
-
Log In
Log In
Log In
Log In
Oceania Growth
-
Log In
Log In
Log In
Log In